TransMedics Group, Inc. logo
TransMedics Group, Inc. (TMDX)
Compare

TransMedics Group, Inc. (TMDX) PB Ratio: 5.77

Is TransMedics Group, Inc.’s P/B ratio high or low?

TransMedics Group, Inc.'s P/B ratio of 5.77 is 62% below its 5-year average of 15.10, near the low end of its 5-year range (4.44–33.79).

56.15% below its 12-month average of 13.16.

TMDX PB Ratio Chart

TMDX PB Ratio
5.77-68.96% 1Y
Zoom

TMDX Average PB Ratio Chart

TMDX Current vs Average PB Ratio Chart

TMDX PB Ratio Metrics

PB RATIO

5.77

PB RATIO AVG TTM

13.16

PB RATIO AVG 3Y

16.94

PB RATIO AVG 5Y

14.85

PB RATIO AVG 10Y

N/A

PB RATIO AVG 15Y

N/A

PB RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-56.15%

CURRENT VS 3Y AVG

-65.95%

CURRENT VS 5Y AVG

-61.13%

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

TMDX Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
TransMedics Group, Inc. (TMDX)$2.72B5.7713.1616.9414.85
DENTSPLY SIRONA Inc. (XRAY)vs ›$2.07B1.571.561.741.88
23andMe Holding Co. (ME)vs ›$15.31M0.510.500.881.62
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.64B1.111.121.141.29
Hims & Hers Health, Inc. (HIMS)vs ›$7.91B18.1516.6813.159.63
Tempus AI, Inc. (TEM)vs ›$8.87B21.8528.6568.9768.97
Charles River Laboratories International, Inc. (CRL)vs ›$8.91B3.082.652.834.00
Baxter International Inc. (BAX)vs ›$10.27B1.701.592.233.03
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B1.441.000.991.29
Revvity, Inc. (RVTY)vs ›$11.16B1.561.501.652.13

P/B vs. its own history

At 5.77, P/B is cheaper than usual, sitting higher than 16% of its 7-year history.

7-year low

2.44

median

10.79

7-year high

33.79

cheaperricher

Book Value Analysis

P/B Ratio

5.77

Market Price / Book Value per Share

TransMedics Group, Inc. PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

TransMedics Group, Inc. PB Ratio FAQ

What is the P/B ratio for TransMedics Group, Inc. (TMDX)?
The P/B ratio for TMDX stock is 5.77.
Is TransMedics Group, Inc.'s P/B ratio high or low?
TransMedics Group, Inc.'s P/B ratio of 5.77 is 62% below its 5-year average of 15.10, near the low end of its 5-year range (4.44–33.79).
What is the TTM average P/B ratio for TransMedics Group, Inc. (TMDX)?
The TTM average P/B ratio for TMDX stock is 13.16.
What is the 3Y average P/B ratio for TransMedics Group, Inc. (TMDX)?
The 3Y average P/B ratio for TMDX stock is 16.94.
What is the 5Y average P/B ratio for TransMedics Group, Inc. (TMDX)?
The 5Y average P/B ratio for TMDX stock is 14.85.

TransMedics Group, Inc. PB Ratio History

DATEPB RATIO
2026-06-185.77
2026-06-175.36
2026-06-165.56
2026-06-155.53
2026-06-125.34
2026-06-115.39
2026-06-105.48
2026-06-095.44
2026-06-085.21
2026-06-055.09
2026-06-045.23
2026-06-035.11
2026-06-025.02
2026-06-014.95
2026-05-294.92
2026-05-284.97
2026-05-275.14
2026-05-265.16
2026-05-225.05
2026-05-215.04
2026-05-204.98
2026-05-194.85
2026-05-185.01
2026-05-154.63
2026-05-144.55
2026-05-134.70
2026-05-124.68
2026-05-114.71
2026-05-084.97
2026-05-075.34
2026-05-065.34
2026-05-056.96
2026-05-048.40
2026-05-018.65
2026-04-308.72
2026-04-298.53
2026-04-288.76
2026-04-279.35
2026-04-249.60
2026-04-239.79
2026-04-229.92
2026-04-219.42
2026-04-209.79
2026-04-1710.02
2026-04-169.44
2026-04-1510.04
2026-04-1410.01
2026-04-139.81
2026-04-109.86
2026-04-099.45
2026-04-089.46
2026-04-079.28
2026-04-069.07
2026-04-028.71
2026-04-018.69
2026-03-318.60
2026-03-308.16
2026-03-278.57
2026-03-268.84
2026-03-259.09
2026-03-249.42
2026-03-239.70
2026-03-209.85
2026-03-199.84
2026-03-189.79
2026-03-1710.79
2026-03-1610.79
2026-03-1310.68
2026-03-1210.49
2026-03-1111.16
2026-03-1011.32
2026-03-0911.66
2026-03-0611.21
2026-03-0512.12
2026-03-0412.77
2026-03-0312.80
2026-03-0212.72
2026-02-2712.57
2026-02-2611.64
2026-02-2511.41
2026-02-2411.92
2026-02-2315.45
2026-02-2015.40
2026-02-1915.24
2026-02-1815.54
2026-02-1715.35
2026-02-1314.90
2026-02-1214.74
2026-02-1115.29
2026-02-1015.98
2026-02-0915.64
2026-02-0615.49
2026-02-0514.87
2026-02-0414.96
2026-02-0315.57
2026-02-0215.37
2026-01-3015.37
2026-01-2915.94
2026-01-2816.17
2026-01-2715.89
2026-01-2615.98
2026-01-2315.52
2026-01-2215.84
2026-01-2115.35
2026-01-2016.28
2026-01-1616.45
2026-01-1516.48
2026-01-1416.29
2026-01-1316.37
2026-01-1215.45
2026-01-0915.72
2026-01-0815.78
2026-01-0715.75
2026-01-0615.22
2026-01-0514.49
2026-01-0214.07
2025-12-3113.96
2025-12-3013.99
2025-12-2914.12
2025-12-2614.25
2025-12-2414.57
2025-12-2314.71
2025-12-2214.84
2025-12-1914.65
2025-12-1813.89
2025-12-1713.99
2025-12-1614.34
2025-12-1514.13
2025-12-1214.55
2025-12-1114.64
2025-12-1015.05
2025-12-0915.46
2025-12-0815.67
2025-12-0515.66
2025-12-0415.90
2025-12-0316.07
2025-12-0216.26
2025-12-0117.26
2025-11-2816.78
2025-11-2616.72
2025-11-2516.75
2025-11-2416.08
2025-11-2115.02
2025-11-2014.20
2025-11-1915.31
2025-11-1813.43
2025-11-1713.01
2025-11-1413.19
2025-11-1313.26
2025-11-1213.67
2025-11-1114.01
2025-11-1014.04
2025-11-0713.67
2025-11-0614.34
2025-11-0514.28
2025-11-0414.02
2025-11-0314.31
2025-10-3115.09
2025-10-3015.58
2025-10-2915.41
2025-10-2816.54
2025-10-2716.89
2025-10-2416.64
2025-10-2316.44
2025-10-2215.24
2025-10-2115.32
2025-10-2015.29
2025-10-1715.00
2025-10-1614.75
2025-10-1514.36
2025-10-1414.18
2025-10-1314.24
2025-10-1013.68
2025-10-0914.41
2025-10-0815.05
2025-10-0714.69
2025-10-0614.53
2025-10-0314.75
2025-10-0214.80
2025-10-0114.65
2025-09-3014.31
2025-09-2914.36
2025-09-2614.52
2025-09-2514.52
2025-09-2414.97
2025-09-2315.37
2025-09-2215.96
2025-09-1915.59
2025-09-1815.44
2025-09-1715.28
2025-09-1615.19
2025-09-1514.57
2025-09-1214.61
2025-09-1114.92
2025-09-1013.74
2025-09-0913.81
2025-09-0813.46
2025-09-0513.26
2025-09-0413.27
2025-09-0313.64
2025-09-0214.22
2025-08-2914.66
2025-08-2814.88
2025-08-2714.97
2025-08-2614.69
2025-08-2514.66
2025-08-2215.28
2025-08-2115.15
2025-08-2015.54
2025-08-1915.64
2025-08-1816.02
2025-08-1516.26
2025-08-1416.54
2025-08-1316.84
2025-08-1216.72
2025-08-1116.23
2025-08-0814.60
2025-08-0714.80
2025-08-0615.15
2025-08-0516.03
2025-08-0416.38
2025-08-0115.37
2025-07-3115.17
2025-07-3013.73
2025-07-2915.71
2025-07-2815.77
2025-07-2516.20
2025-07-2416.01
2025-07-2316.48
2025-07-2215.83
2025-07-2115.53
2025-07-1816.47
2025-07-1716.86
2025-07-1616.98
2025-07-1517.34
2025-07-1417.52
2025-07-1116.86
2025-07-1018.70
2025-07-0918.95
2025-07-0818.69
2025-07-0718.76
2025-07-0319.36
2025-07-0219.14
2025-07-0119.50
2025-06-3020.09
2025-06-2719.70
2025-06-2619.49
2025-06-2519.27
2025-06-2419.88
2025-06-2319.11
2025-06-2018.52
2025-06-1818.59
2025-06-1720.41
2025-06-1621.28
2025-06-1321.41
2025-06-1221.44
2025-06-1121.41
2025-06-1021.11
2025-06-0920.89
2025-06-0620.84

Showing the most recent 260 of 1,725 data points. The chart above shows the full history.

About TransMedics Group, Inc.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

Andover, MA
728 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Waleed H. Hassanein